/PRNewswire/ ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Surgery (ASCRS).
/PRNewswire/ ZEISS Medical Technology announced that it has received 510(k) clearance from the FDA for MTLawton™. These new disposable bipolar forceps are.
ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care. JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ ZEISS
The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care. JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advance the future of transformative care in ophthalmology.At ZEISS Innovation Week, September 6-8, 2022, ZEISS Medical Technology will host leading experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management and a range of new software applications are enabling improved efficiencies and optimization of patient care. ZEISS will also exhibit at the European Society of Cataract and Refractive Surgeons(ESCRS) Annual Meeting, September 16-20, and the American Academy of Ophthalmology(AAO) Conference, Sept. 30 - Oct. 3, providing demos, educational programs, and scientific events discussing how digital technologies can promote clinical effici